The Cautionary Notice In Myanmar

In Myanmar, there is no Trademark Law. Protection for a trademark can only be obtained by filing an application together with a Power of Attorney and a Declaration of Ownership. The Declaration of Ownership is then registered with the Office of the Registration of Deeds, to which is assigned an application date and number as […]

Kingdom of Nepal Joins Berne Convention

The provisions of the Berne Convention for the Protection of Literary and Artistic Works came into force on January 11, 2006 in Nepal. The Copyright Act 2059 B.S. (enacted in 2002) had already incorporated the provisions of the Berne Convention related to copyrights and intellectual property rights protection. This Convention adopted at Berne in 1886 […]

India – TRIPS Compliance – the Unfinished Agenda

India’s Commerce & Industries Minister constituted a Technical Expert Committee to study two critical issues which were not considered by the Parliament when passing the Patents (Amendment) Act 2005. Issues concerning patentability of ‘new chemical entities’ and ‘micro-organisms’ were referred to the Expert Committee. If any amendments are suggested to safeguard the interests of these […]

“New Use Claims” – New Indian patent law heralds fundamental changes

The recently promulgated Indian Patent Ordinance indirectly recognizes ‘new uses’ as patentable in India. Thus far, new use of a known substance was unpatentable. Section 3 of the Indian Patents Act 1970 excluded ‘new use’ from the scope of patentable inventions. The recent amendment enables pharmaceutical companies to protect new use of patented drug molecules, […]

The Military Government issues more compulsory licenses

On 25th January 2007, Thailand’s military government stunned the pharmaceutical industry by their decision to issue more compulsory licenses with respect to drugs for treatment of heart diseases and AIDS. Earlier, in November last year, Thailand had issued its first compulsory license for making Efavirenz, an anti-retroviral drug manufactured by US pharmaceutical company Merck & […]